The fifth Iranian-made COVID-19 vaccine has been permitted to undergo the Phase II of its clinical trial.
The recombinant vaccine has been produced by Cinnagen company, and is the first one developed by the private sector.
Four other homegrown vaccines are already undergoing their clinical trials at different phases.
The Covo-Pars vaccine developed by Razi Institute, the conjugate vaccine jointly developed by Iran’s Pasteur Institute and Cuba’s Finlay Institute, the CovIran Barekat vaccine funded by the Executive Office of Imam Khomeini’s Order, and the Fakhra vaccine funded by the Iranian Ministry of Defence are the other four vaccines that are passing their final tests.
Aid items donated by millions of Iranians within a national campaign, have reached the beseiged…
Iran's Deputy Foreign Minister Majid Takht Ravanchi has said Iran and Saudi Arabia are committed…
Behrouz Kamalvandi, the spokesperson for the Atomic Energy Organization of Iran (AEOI), says the organization…
Hundreds of people gathered in Tehran on Friday morning in front of the United Nations…
An international law expert and analyst has revealed the U.S. plans to impose punitive measures…
Iran’s Minister of Science, Research, and Technology, Hossein Simayee Saraf, addressed on Thursday academic migration…